AHR regulates the immunomodulatory function of human adipose-derived mesenchymal stem cells

doi:10.16352/j.issn.1001-6325.2023.06.0889

Abstract

Abstract: Objective To explore the effect of aryl hydrocarbon receptor(AHR) on the immunomodulatory function of human adipose derived mesenchymal stem cells (MSCs). Methods RT-qPCR and immunofluorescence staining were used to detect the expression levels of indoleamine 2,3-dioxygenase 1 (IDO1), interleukin-4-inducible gene 1 (IL4I1) and AHR in MSCs before and after inflammatory cytokine stimulation; siCtrl, siIDO1, siIL4I1 and siAHR were transfected into MSCs and blocked the AHR signaling pathway; conditioned medium from MSCs was co-incubated with macrophages, RT-qPCR and ELISA were performed to detect the level of IL-6, IL-1β, TNF-α. Results MSCs without cytokine stimulation highly expressed AHR and hardly expressed IDO1 and IL4I1 proteins; IDO1, IL4I1 and AHR were up-regulated after different cytokine stimulation(P＜0.05), the expression of IDO1 and IL4I1 was most significantly up-regulated after stimulation by IFN-γ(P＜0.001), AHR entering the nucleus was increased; down-regulation of AHR expression could inhibit the immunomodulatory effect of MSCs(P＜0.05). Conclusions AHR regulates the immune function of MSCs, downregulates expression of AHR could inhibit the immunomodulatory effects of MSCs.

Key words: aryl hydrocarbon receptor(AHR), mesenchymal stem cells, immunomodulatory effects

CLC Number:

Q291

WU Wenjing, GAO Jingxi, ZHAO Xiaoyan, SUN Zhao, HAN Qin, ZHAO Chunhua. AHR regulates the immunomodulatory function of human adipose-derived mesenchymal stem cells[J]. Basic & Clinical Medicine, 2023, 43(6): 889-897.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.06.0889

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I6/889

References 15

[1]	Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8: 315-317.
[2]	Lai P, Weng J, Guo L, et al. Novel insights into MSC-EVs therapy for immune diseases[J]. Biomark Res, 2019,7:6. doi: 10.1186/s40364-019-0156-0.
[3]	Zhu R, Yan T, Feng Y, et al. Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms[J]. Cell Res, 2021, 31: 1244-1262.
[4]	Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases[J]. Nat Rev Nephrol, 2018, 14: 493-507.
[5]	Dhingra S, Li P, Huang XP, et al. Preserving prostaglandin E2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores postinfarction ventricular function[J]. Circulation, 2013, 128: S69-S78.
[6]	Wang Y, Chen X, Cao W, et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications[J]. Nature Immunology, 2014, 15: 1009-1016.
[7]	Sadik A, Somarribas PL, Ozturk S, et al. IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression[J]. Cell, 2020, 182: 1252-1270.
[8]	Rothhammer V, Quintana FJ. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease[J]. Nat Rev Immunol, 2019, 19: 184-197.
[9]	Gutierrez-Vazquez C, Quintana FJ. Regulation of the immune response by the aryl hydrocarbon receptor[J]. Immunity, 2018, 48: 19-33.
[10]	Xu Q, Wang L, Li H, et al. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-beta[J]. Int J Oncol, 2012, 41: 959-968.
[11]	Zhu W, Yuan Y, Liao G, et al. Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy[J]. Cell Death Dis, 2018. doi: 10.1038/s41419-018-0861-x.
[12]	Deng L, Li H, Su X, et al. Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation[J]. Cell Death Dis, 2020,11:158. doi: 10.1038/s41419-020-2357-8.
[13]	Renesme L, Pierro M, Cobey KD, et al. Definition and characteristics of mesenchymal stromal cells in preclinical and clinical studies: a scoping review[J]. Stem Cells Transl Med, 2022, 11: 44-54.
[14]	Zhang C, Zhou L, Wang Z, et al. Eradication of specific donor-dependent variations of mesenchymal stem cells in immunomodulation to enhance therapeutic values[J]. Cell Death Dis, 2021,12:357. doi: 10.1038/s41419-021-03644-5.
[15]	Yao M, Cui B, Zhang W, et al. Exosomal miR-21 secreted by IL-1beta-primed-mesenchymal stem cells induces macrophage M2 polarization and ameliorates sepsis[J]. Life Sci, 2021,264:118658. doi: 10.1016/j.lfs.2020.118658.